ArticleInternational journal of clinical oncology2026

Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI).

Taro Shibuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.